cefixime has been researched along with Urethritis in 12 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Urethritis: Inflammation involving the URETHRA. Similar to CYSTITIS, clinical symptoms range from vague discomfort to painful urination (DYSURIA), urethral discharge, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this randomized study, a single 800-mg oral dose of cefixime cured 96 of 97 men with uncomplicated gonococcal urethritis, compared with 44 cures of 46 men who received standard therapy with amoxicillin (3 g) plus probenecid (1 g)." | 9.06 | Single-dose oral cefixime versus amoxicillin plus probenecid for the treatment of uncomplicated gonorrhea in men. ( Bowie, WR; Lefebvre, K; Megran, DW; Willetts, V, 1990) |
| " Subsequently, a dosing interval of 6 h was tested in 6 healthy Japanese men, and then 93 Japanese men with gonococcal urethritis were treated with a regimen of two 200-mg doses of cefixime given at a 6-h interval." | 5.32 | Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. ( Deguchi, T; Harada, Y; Ishida, K; Ishihara, S; Ito, M; Kojima, K; Maeda, S; Minamidate, K; Tamaki, M; Tei, K; Yasuda, M; Yokoi, S, 2003) |
| "In this randomized study, a single 800-mg oral dose of cefixime cured 96 of 97 men with uncomplicated gonococcal urethritis, compared with 44 cures of 46 men who received standard therapy with amoxicillin (3 g) plus probenecid (1 g)." | 5.06 | Single-dose oral cefixime versus amoxicillin plus probenecid for the treatment of uncomplicated gonorrhea in men. ( Bowie, WR; Lefebvre, K; Megran, DW; Willetts, V, 1990) |
| "Oral regimens for the treatment of gonorrhea are limited." | 2.46 | Emergence and spread of drug resistant Neisseria gonorrhoeae. ( Deguchi, T; Maeda, S; Nakane, K; Yasuda, M, 2010) |
| " Subsequently, a dosing interval of 6 h was tested in 6 healthy Japanese men, and then 93 Japanese men with gonococcal urethritis were treated with a regimen of two 200-mg doses of cefixime given at a 6-h interval." | 1.32 | Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. ( Deguchi, T; Harada, Y; Ishida, K; Ishihara, S; Ito, M; Kojima, K; Maeda, S; Minamidate, K; Tamaki, M; Tei, K; Yasuda, M; Yokoi, S, 2003) |
| "Cefixime was kept for patients not responding to the first GU treatment." | 1.31 | Cost-effectiveness of management strategies for acute urethritis in the developing world. ( Crabbé, F; de Clerck, M; Laga, M; Vuylsteke, B, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yasuda, M | 4 |
| Takahashi, S | 3 |
| Miyazaki, J | 1 |
| Wada, K | 1 |
| Kobayashi, K | 2 |
| Matsumoto, M | 1 |
| Hayami, H | 2 |
| Yamamoto, S | 2 |
| Kiyota, H | 3 |
| Sato, J | 2 |
| Matsumoto, T | 2 |
| Yotsuyanagi, H | 1 |
| Hanaki, H | 2 |
| Masumori, N | 1 |
| Hiyama, Y | 2 |
| Nishiyama, H | 1 |
| Kimura, T | 1 |
| Yamada, H | 1 |
| Matsumoto, K | 1 |
| Ishikawa, K | 2 |
| Togo, Y | 1 |
| Tanaka, K | 2 |
| Sadahira, T | 1 |
| Inokuchi, J | 1 |
| Hamasuna, R | 2 |
| Ito, K | 2 |
| Hirayama, H | 2 |
| Hayashi, K | 1 |
| Kurimura, Y | 2 |
| Kadena, H | 2 |
| Ito, S | 2 |
| Shiono, Y | 1 |
| Maruyama, T | 1 |
| Ito, M | 3 |
| Hatano, K | 1 |
| Chokyu, H | 2 |
| Ihara, H | 1 |
| Uno, S | 2 |
| Monden, K | 2 |
| Yokoyama, T | 1 |
| Kano, M | 2 |
| Kaji, S | 2 |
| Kawahara, M | 2 |
| Sumii, T | 2 |
| Tojo, T | 1 |
| Hosobe, T | 2 |
| Naito, K | 1 |
| Kawai, S | 2 |
| Nishimura, H | 2 |
| Izumitani, M | 1 |
| Yoh, M | 2 |
| Matsumura, M | 2 |
| Fujita, R | 1 |
| Takayama, K | 2 |
| Hara, M | 1 |
| Nishi, S | 2 |
| Uehara, S | 1 |
| Minamitani, S | 1 |
| Watanabe, A | 1 |
| Iwata, S | 1 |
| Kaku, M | 1 |
| Kadota, J | 1 |
| Sunakawa, K | 1 |
| Tsukamoto, T | 2 |
| Egawa, S | 1 |
| Arakawa, S | 1 |
| Fujisawa, M | 1 |
| Kumon, H | 1 |
| Matsubara, A | 1 |
| Naito, S | 1 |
| Kuroiwa, K | 1 |
| Narita, H | 1 |
| Yoshioka, M | 1 |
| Yamaguchi, T | 1 |
| Maeda, S | 3 |
| Shirane, T | 1 |
| Akiyama, K | 1 |
| Imai, T | 1 |
| Peters, RP | 1 |
| Verweij, SP | 1 |
| McIntyre, JA | 1 |
| Schaftenaar, E | 1 |
| Osaka, K | 1 |
| Takakura, T | 1 |
| Narukawa, K | 1 |
| Takahata, M | 1 |
| Endo, K | 1 |
| Onodera, S | 1 |
| Brill, JR | 1 |
| Deguchi, T | 2 |
| Nakane, K | 1 |
| Hashimoto, J | 1 |
| Uehara, T | 1 |
| Iwasawa, A | 1 |
| Nishimura, M | 1 |
| Sunaoshi, K | 1 |
| Takeda, K | 1 |
| Suzuki, N | 1 |
| Yokoi, S | 1 |
| Ishida, K | 1 |
| Ishihara, S | 1 |
| Minamidate, K | 1 |
| Harada, Y | 1 |
| Tei, K | 1 |
| Kojima, K | 1 |
| Tamaki, M | 1 |
| Crabbé, F | 1 |
| Vuylsteke, B | 1 |
| de Clerck, M | 1 |
| Laga, M | 1 |
| Plourde, PJ | 1 |
| Tyndall, M | 1 |
| Agoki, E | 1 |
| Ombette, J | 1 |
| Slaney, LA | 1 |
| D'Costa, LJ | 1 |
| Ndinya-Achola, JO | 1 |
| Plummer, FA | 1 |
| Asbach, HW | 1 |
| Megran, DW | 1 |
| Lefebvre, K | 1 |
| Willetts, V | 1 |
| Bowie, WR | 1 |
1 review available for cefixime and Urethritis
| Article | Year |
|---|---|
Emergence and spread of drug resistant Neisseria gonorrhoeae.
Topics: Azithromycin; Cefixime; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Neisseria g | 2010 |
3 trials available for cefixime and Urethritis
| Article | Year |
|---|---|
Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftriaxone; Drug Ev | 1992 |
Single dose oral administration of cefixime 400mg in the treatment of acute uncomplicated cystitis and gonorrhoea.
Topics: Acute Disease; Administration, Oral; Cefixime; Cefotaxime; Cystitis; Double-Blind Method; Female; Go | 1991 |
Single-dose oral cefixime versus amoxicillin plus probenecid for the treatment of uncomplicated gonorrhea in men.
Topics: Adolescent; Adult; Amoxicillin; Cefixime; Cefotaxime; Gonorrhea; Humans; Male; Probenecid; Randomize | 1990 |
8 other studies available for cefixime and Urethritis
| Article | Year |
|---|---|
The third nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2016-2017.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Gonorrhea; Humans | 2023 |
The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance | 2015 |
Gonococcal Conjunctivitis Despite Successful Treatment of Male Urethritis Syndrome.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Conjunctivitis; Gonorrhea; Humans; Male; Neisseria go | 2016 |
Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Ceftriaxone; Drug Resistance, | 2008 |
Diagnosis and treatment of urethritis in men.
Topics: Adolescent; Adult; Azithromycin; Black or African American; Cefixime; Ceftriaxone; Chlamydia Infecti | 2010 |
Antimicrobial susceptibility and penicillin-binding protein 1 and 2 mutations in Neisseria gonorrhoeae isolated from male urethritis in Sapporo, Japan.
Topics: Anti-Bacterial Agents; Cefixime; Cephalosporin Resistance; Cephalosporins; Gonorrhea; Humans; Japan; | 2013 |
Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval.
Topics: Anti-Bacterial Agents; Cefixime; Drug Administration Schedule; Gonorrhea; Humans; Male; Microbial Se | 2003 |
Cost-effectiveness of management strategies for acute urethritis in the developing world.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cost-Benefit Analysis; Decisi | 2000 |